NCT05082610
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05082610
Title A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hummingbird Bioscience
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The City of Hope National Medical Center Duarte California 91010 United States Details
Cedars-Sinai Medical Center Los Angeles California 90048 United States Details
Stanford Cancer Institute Palo Alto California 94304 United States Details
Smilow Cancer Hospital - Yale New Heaven Health New Haven Connecticut 06511 United States Details
UTSW Medical Center Dallas Texas 75390 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field